Effect of growth hormone in the treatment of infertility

Phase 1

• Conditions: Women infertility.; Women infertility

• Registration Number: IRCT20210220050429N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 25

Inclusion Criteria

25 infertile women aged 19-45 years with a history of endometrial thickness less than 7 mm on the last day of endometrial preparation with estrogen in the previous cycle of embryo transfer.

Exclusion Criteria

Age over 45 years, Diabetic patients, History of cancer, Cardiovascular disease, Any disease that threatens the mother's life and prohibits pregnancy and fetal transfer, Uterus with adenomyosis and uterine fibroids, History of thrombosis, liver disease, Dyslipidemia

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Check of serum BHCG.;Clinical pregnancy. Timepoint: 4weeks after embryo transfer. Method of measurement: Seeing intra uterine gestational sac in vaginal sonography.;Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Sonography and see the heart beat of embryo.;Increase in endometrial thickness after intrauterine infusion of growth hormone. Timepoint: Measurement endometrial thickness at the beginning and at the end day of intrauterine growth hormone injection. Method of measurement: Trans sagittal vaginal sonography.